Effect of Recombinant Human Insulin-like Growth Factor 1 on the Blood Glucose of db/db Mice

Liang ZHOU,Lan CUI,Dongchun LIANG
DOI: https://doi.org/10.3969/j.issn.0253-9896.2009.05.017
2009-01-01
Abstract:Objective:To study blood glucose regulation effect of recombinant human insulin -like growth factor 1 (rhIGF-1) on db/db defective leptin receptor mice which acted as the animal model of type 2 diabetes. Methods: Six-week old db/db and normal mice from the same strain were fed normally. Blood glucose, serum insulin and serum IGF-1 were monitored every three days. When db/db mice showed the significant evidence of hyperglycemia and hyperinsulinemia, they were divided into four groups randomly and subjected to the treatment of subcutaneous injection of solvent, insulin and rhIGF-1 of high and low doses for two weeks. Blood glucose was measured every 30 minutes after the first administration, and the effects of regulating blood glucose with different intervention methods were observed. The levels of blood glucose before every administration were evaluated, and the trends of blood glucose were observed. Results: db/db mice were characterized by hyperglycemia and hyperinsulinemia at the eighth week. There was no significant effect of insulin on blood glucose decrease. High-dose IGF-1 could decrease the blood glucose to normal level 6 days after the treatment, and could avoid the high level of blood glucose. Conclusion: The effect of rhIGF-1 on regulating blood glucose is much better than that of insulin in db/db mice. This result could contribute to the potential of using rhIGF-1 for the treatment of diabetes with severe insulin resistance.
What problem does this paper attempt to address?